Peter Attia· MD
I've been on G6 for a year (using it before it came to market).
Loading…
The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
I've been on G6 for a year (using it before it came to market).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
Used to happen with 5, but 60 days with 6 has not produced this.
After 4 years of being an on-the-belly CGM guy, I’m taking the plunge and going back-of-the-arm style with the Dexcom G6.
Dexcom closer to 7%.
I have not worn it yet, but know several who have.
Correct, I don't use receiver.
and I look at a 90 day trailing CGM so I use the Dexcom g6 I'm pretty much always wearing it even though obviously you change it out every 10 days and I just look you can generate reports what's my trailing 7 day 14 day 21 day 30 day 60 ninety-day blood glucose
Post-meal glucose spikes in non-diabetics drive long-term cardiometabolic disease independently of HbA1c.
Wearing a continuous glucose monitor leads to personalized dietary improvements that hold up beyond 12 weeks.
Continuous glucose monitors meaningfully change behavior in non-diabetic adults beyond the first month.
CGM use in metabolically healthy adults induces orthorexic-style dietary anxiety without health benefit.